Efficacy and safety of (a) A-Lfor Plasmodium falciparum and (b) P-A for Plasmodium falciparum and Plasmodium vivax malaria in Ta-mu Township, Sagaing Regio

Not Applicable

Withdrawn

• Conditions: malaria related fever; headache; ache; mailaise; loss of appetite; Public Health - Other public health; Infection - Other infectious diseases

• Registration Number: ACTRN12618001476224
• Lead Sponsor: WHO country office

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2018-09-04
• Last Update Posted: 26 August 2019

Recruitment & Eligibility

• Status: Withdrawn
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

Patients having fever with a parasitological count of more than 1000 asexual parasites per 1 ul of blood for P.falciparum malaria and 500 asexual parasites per 1 ul for P. vivax malaria

Exclusion Criteria

Patients having severe and complicated malaria

Study & Design

• Study Type: Interventional
• Study Design: Not specified